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Abstract
Kaposi's sarcoma-associated herpesvirus origin-dependent DNA replication requires the core replication proteins plus K-Rta and K-bZIP. To
determine which K-bZIP protein domains contribute to oriLyt-dependent DNA replication and facilitate suppression of K-Rta-mediated
transcriptional activation, we generated a series of deletion constructs and site-directed mutations within the K-bZIP ORF. Mutation of key leucine
residues within the putative leucine zipper (LZ) motif eliminated the ability of the protein to homodimerize and complement oriLyt-dependent
DNA replication. Deletion of the basic amino acid region (BR) or LZ domain did not affect the ability of K-bZIP to bind to K-Rta indicating that
either region contributes to heterodimerization with K-Rta. However, deletions or mutations introduced into both the LZ and BR resulted in
elimination of the suppressive activity of K-bZIP even in the presence of a K-bZIP–K-Rta interaction. Interestingly, mutants that lacked the ability
to suppress K-Rta transactivation were still capable of complementing oriLyt-dependent DNA replication, indicating that this activity does not
contribute to the DNA synthesis-related activity of K-bZIP.
© 2007 Elsevier Inc. All rights reserved.Keywords: DNA replication; Herpesvirus; Transactivation; Leucine zipperIntroduction
Kaposi's sarcoma-associated herpesvirus or human herpes-
virus 8 (HHV8) lytic DNA replication requires 6 core
replication proteins common to the herpesvirus family. These
proteins, ORF6 (single-stranded DNA binding protein), ORF9
(DNA polymerase), ORF40/41 (primase-associated factor),
ORF44 (helicase), ORF56 (primase), and ORF59 (polymerase
processivity factor), provide the enzymatic machinery for
replication of viral DNA (AuCoin et al., 2004a). In addition
to these core proteins, two other viral-encoded proteins are
required for origin-dependent DNA replication. These proteins,
ORF50 (K-Rta) and K8 (K-bZIP), supply an as yet undeter-
mined activity.
K-Rta is the major transactivator for HHV8 and is
responsible for the switch from latency to lytic replication⁎ Corresponding author.
E-mail address: gpari@medicine.nevada.edu (G. Pari).
0042-6822/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2007.08.019(Byun et al., 2002; Gradoville et al., 2000; Lukac et al., 1999;
Wang et al., 2001). K-Rta has autoregulatory properties, with
respect to DNA binding and its own expression, and was shown
to activate both immediate early as well as early genes,
including K8 (K-bZIP) (Byun et al., 2002; Chang and Miller,
2004; Deng et al., 2000; Lukac et al., 2001). Recent studies
indicated that the expression of K-Rta in the context of the viral
genome is required for lytic replication and activation of several
viral encoded proteins (Xu et al., 2005). With respect to the role
of K-Rta in DNA replication, current data indicate that K-Rta
activates a K-Rta-responsive promoter within oriLyt and
suggests that initiation of DNA synthesis is triggered by a
transcription event. This mode of initiation of lytic DNA
synthesis would be consistent with that proposed for both
Epstein Barr Virus (EBV) and human cytomegalovirus
(HCMV) (Hammerschmidt and Sugden, 1988; Schepers et al.,
1993, 1996).
The role of K-bZIP in DNA replication is less clear. K-bZIP
interacts with K-Rta and suppresses the transactivation activity
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2003a; Liao et al., 2003). K-bZIP was also implicated in
controlling the cell cycle by directly binding to cyclin-CDK2
(Izumiya et al., 2003b). Since K-bZIP has no reported
transactivation function, the assumption is that a direct or
indirect interaction with oriLyt provides an enzymatic activity
or some other role that orchestrates initiation of DNA synthesis.
Consistent with this model, K-bZIP was shown to interact with
oriLyt via CCAAT enhancer binding sites within oriLyt through
an indirect or “piggyback” interaction with CCAAT enhancer
binding protein alpha (C/EBPα) in BCBL-1 cells (Wang et al.,
2003a,b).
Our previous studies demonstrated that the oriLyt-dependent
DNA replication-associated activity of K-bZIP requires the
presence of an intact leucine zipper motif (AuCoin et al.,
2004a). Apparently, the region containing the leucine zipper is
required for multimerization, but does not form the traditional
coiled-coil structure (Al Mehairi et al., 2005). The BR plus the
leucine zipper motif was demonstrated to comprise the region of
interaction between K-bZIP and C/EBPα (Wang et al., 2003a).
Consequently, the K-bZIP leucine zipper and BR amino acid
motifs are key protein domains essential for the interaction with
cellular and other viral encoded proteins. This suggests that the
replication function supplied by K-bZIP may be distinct from
that supplied by the closely related Zta protein of Epstein Barr
Virus (EBV). In EBV, Zta provides a transactivation function as
well as a replication activity within oriLyt by interacting with
several defined Zta response elements (ZREs) (Fixman et al.,
1992; Sarisky et al., 1996).
There is an apparent discrepancy surrounding which motif is
required for interaction with, and for suppression of, K-Rta-
mediated transcriptional activation. Two contradicting reports
show that either the BR or the LZ region is the point of
interaction between K-bZIP and K-Rta (Izumiya et al., 2003a;
Liao et al., 2003). Liao et al. report that a deletion of the leucine
zipper region of K-bZIP abrogates its suppressive affects;
however, Izumiya et al. report that deletion of the BR region
resulted in a loss of suppression of K-Rta-mediated transactiva-
tion (deletion of the LZ had no effect). This controversy served
as a major impetus for our investigation of the binding domains
of K-bZIP and how repression of K-Rta-mediated transactiva-
tion relates to DNA synthesis.
In this report, we defined the K-bZIP point of interaction
required for both homodimerization of K-bZIP and hetero-
dimerization with K-Rta. We show that point mutations
introduced into the leucine zipper motif disrupt the ability of
K-bZIP to homodimerize and fail to complement oriLyt-
dependent DNA replication. In addition, K-bZIP LZ mutants
that fail to homodimerize no longer inhibit the transactivation
activity of K-Rta. Deletion of both the LZ and BR domains of K-
bZIP is required to eliminate a K-bZIP–K-Rta interaction,
indicating that either structure can interact with K-Rta.Mutations
introduced into the BR region of K-bZIP did not interfere with
binding to K-Rta, but affect the ability of K-bZIP to repress K-
Rta-mediated transactivation and oriLyt amplification. Finally,
we show that the suppression of K-Rta transactivation byK-bZIP
does not contribute to oriLyt-dependent DNA replication.Results and discussion
The K-bZIP leucine zipper and the basic amino acid region
contribute to homodimerization
The first step to defining a region within the K-bZIP protein
that contributes to a self-interaction is to identify a deletion
mutant that no longer forms a dimer. We generated 7 HA-tagged
expression plasmids each with a different 33 amino acid
deletion in the K-bZIP ORF (Fig. 1A). Deletion plasmids were
each cotransfected with a full-length wt K-bZIP expression
plasmid that was FLAG tagged. Protein extracts were prepared
and immunoprecipitated with anti-FLAG antibody. An interac-
tion between the two K-bZIP species was detected by reacting
Western blot of the immunoprecipitated protein with an anti-HA
antibody. All of the K-bZIP deletion proteins interacted with wt
K-bZIP except deletion number 6 (D6) (Fig. 1B, lane 6). K-
bZIP D6 has a 33 amino acid deletion that removed the entire
BR region and most of the LZ motif, leaving leucine residues
205, 212, and 219 of the LZ domain. All FLAG and HA-tagged
K-bZIP proteins were similarly expressed (Fig. 1B, see FLAG
and HA Lysates) and all FLAG-tagged protein species were
efficiently immunoprecipitated (Fig. 1B, see FLAG IP FLAG
West). These results show that the region between amino acids
169 and 202 of the K-bZIP ORF contributes to homodimeriza-
tion and confirms earlier reports implicating the LZ and BR
domains.
The leucine zipper domain of K-bZIPmediates homodimerization
The co-immunoprecipitation experiment showed that the
region of K-bZIP containing the LZ and BR domains is required
for homodimerization. In addition, since K-bZIP is known to
exist as a dimer in transfected and infected cells (Al Mehairi et
al., 2005; Izumiya et al., 2003a), we wanted to investigate if
dimerization of K-bZIP was involved in, or required for, the
DNA replication function conferred by the protein.
Fig. 2A is a schematic of the ORF50 and K-bZIP genomic
region. Also shown are the domains of interest within the K-
bZIP ORF (Fig. 2A). The putative basic region (BR) for K-bZIP
was identified as containing six basic amino acids (Fig. 2A) and
the putative leucine zipper (LZ) encompasses leucine residues
and an isoleucine residue at amino acids 191, 198, 205, 212, and
219 (Fig. 2A). In order to study the contribution of these
domains to homodimerization, we altered several leucine
residues within the LZ using site-directed mutagenesis and
assayed the ability of these mutants to interact with wt K-bZIP
using the co-immunoprecipitation assay (Fig. 2C).
293T cells were cotransfected with FLAG tagged LZ
mutants (Fig. 2B) along with wild-type HA tagged K-bZIP.
The differentially tagged proteins allowed us to detect binding
between mutant and wild-type K-bZIP species upon co-
immunoprecipitation by anti-FLAG antibodies followed by
Western blot analysis using HA specific antibodies. Under these
cotransfection conditions, leucine zipper mutants LZ-1 and LZ-
2 failed to interact with K-bZIP-HA (Fig. 2C). Control lysates
showed that all proteins were expressed efficiently and at
Fig. 2. K-bZIP homodimerization requires an intact LZ. (A) Schematic showing
the K-bZIP ORF and amino acid residues comprising the BR (basic region) and
LZ (leucine zipper). (B) Amino acid sequence of the leucine zipper motif and the
location of mutations introduced into key leucine residues to generate K-bZIP
mutants LZ-1, LZ-2, and LZ-3 and LZ-205. (C) Cotransfection and
immunoprecipitation of wt K-bZIP with leucine zipper mutants. Assays were
performed as described previously.
Fig. 1. K-bZIP protein lacking the BR and LZ domains fail to homodimerize. (A)
Genomic arrangements of nucleotide coordinates for ORF50 and K-bZIP and a
schematic of the K-bZIP ORF showing the basic amino acid region (BR) and
leucine zipper motif (LZ) and HA tag. Also shown are the 7 in frame deletion
mutants generated for K-bZIP and the designated amino acids that were deleted.
(B) Western blot of co-immunoprecipitation assay of K-bZIP deletion mutants
and wt K-bZIP. Cells were transfected and treated as described in Materials and
methods. Lanes: wt-K-bZIP-FLAG, transfection, and immunoprecipitation of
control K-bZIP-FLAG protein; wt K-bZIP-FLAG and wt K-bZIP-HA,
cotransfection control plasmids and immunoprecipitation of FLAG and HA
tagged wt K-bZIP protein; 1, protein samples from cotransfection of wt K-bZIP-
HA and D1; 2, protein samples from cotransfection of wt K-bZIP-HA and D2; 3,
protein samples from cotransfection of wt K-bZIP-HA and D3; 4, protein
samples from cotransfection of wt K-bZIP-HA and D4; 5, protein samples from
cotransfection of wt K-bZIP-HA and D5; 6, protein samples from cotransfection
of wt K-bZIP-HA and D6; 7, protein samples from cotransfection of wt K-bZIP-
HA and D7. FLAG Lysate: protein samples from transfections reacted with anti-
FLAG antibody, HA Lysate: protein samples from transfections reacted with
anti-HA antibody, FLAG IP HAWest: cotransfections were immunoprecipitated
with anti-FLAG antibody andWestern blots were reacted with anti-HA antibody,
FLAG IP FLAG West: cotransfections were immunoprecipitated with anti-
FLAG antibody and Western blots were reacted with anti-FLAG antibody.
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indicated that the LZ motif of K-bZIP, especially residues 198
and 205, is essential for efficient homodimerization.K-bZIP requires an intact BR/LZ region to interact with K-Rta
Since it was previously reported that there is an interaction
between K-bZIP and the viral transactivator ORF50 (K-Rta), we
next wanted to evaluate the ability of the K-bZIP deletion
mutants to interact with K-Rta. Cells were cotransfected with
plasmids expressing each K-bZIP deletion mutant (from Fig.
1A) and a K-Rta expression plasmid containing an in-frame
FLAG epitope. Co-immunoprecipitation assays were performed
and precipitated protein complexes were analyzed by Western
blot. Consistent with the K-bZIP homodimerization results, K-
bZIP deletion mutant D6 failed to interact with K-Rta (Fig. 3C).
The next step was to determine which specific K-bZIP
domain(s) was responsible for interacting with K-Rta. It was
previously reported that the BR of K-bZIP alone could interact
with K-Rta (Izumiya et al., 2003a). However, another report
found that only the K-bZIP leucine zipper motif was the point of
interaction between the two proteins (Liao et al., 2003). Both of
these studies used peptide fragments of K-bZIP protein
corresponding to the LZ or BR regions to analyze these
interactions. We were interested in the binding characteristics of
K-bZIP with K-Rta in the context of the complete protein
coding region minus the BR, LZ, or other protein domains. As
stated earlier, the BR region of K-bZIP consists of six amino
acids just upstream of the LZ motif (Fig. 1A). We used site-
directed mutagenesis to generate 9 K-bZIP expression plasmids
Fig. 3. Interaction of K-bZIP BR and LZ mutants with K-Rta. (A) Schematic of expression plasmids where either the LZ or the BR of K-bZIP was deleted from the
ORF and (B) expression plasmids where amino acid residue changes were introduced into the K-bZIP BR or LZ domains in the backbone of BR or LZ deletion
mutants. (C) Co-immunoprecipitation of K-Rta with K-bZIP deletion mutants. Lanes:Wt K-bZIP-HAWt K-Rta-FLAG, cotransfection and immunoprecipitation of Wt
K-bZIP and wt K-Rta; 1, cotransfection and immunoprecipitation of D1 and wt K-Rta; 2, cotransfection and immunoprecipitation of D2 and Wt K-Rta; 3,
cotransfection and immunoprecipitation of D3 and Wt K-Rta; 4, cotransfection and immunoprecipitation of D4 and wt K-Rta; 5, cotransfection and
immunoprecipitation of D5 andWt K-Rta; 6, cotransfection and immunoprecipitation of D6 and wt K-Rta; 7, cotransfection and immunoprecipitation of D7 and wt K-
Rta. (D) Amino acid residue mutations introduced into the BR domain of K-bZIP have no effect on K-Rta binding. Western blot of co-immunoprecipitated protein–
protein interactions between various K-bZIP BR mutants and wt K-RTA. (E) K-bZIP leucine zipper mutants interact with K-Rta. Western blot of co-
immunoprecipitated protein samples from cotransfections of K-bZIP mutants lacking either the BR or LZ, plus D6 as negative control, and wt K-Rta. (F) BR or LZ
regions of K-bZIP can interact with K-Rta. FLAG Lysate: protein samples from transfections reacted with anti-FLAG antibody, HA Lysate: protein samples from
transfections reacted with anti-HA antibody, FLAG IP HAWest: cotransfections were immunoprecipitated with anti-FLAG antibody and Western blots were reacted
with anti-HA antibody, FLAG IP FLAG West: cotransfections were immunoprecipitated with anti-FLAG antibody and Western blots were reacted with anti-FLAG
antibody. (G) Mutations in the LZ and BR abrogate the K-bZIP–K-Rta interaction. Western blot of co-immunoprecipitated protein samples from cotransfection of
various K-bZIP BR-LZ mutants and wt K-Rta. FLAG Lysate: protein samples from transfections reacted with anti-FLAG antibody, HA Lysate: protein samples from
transfections reacted with anit-HA antibody, FLAG IP HAWest: cotransfections were immunoprecipitated with anti-FLAG antibody and Western blots were reacted
with anti-HA antibody, FLAG IP FLAG West: cotransfections were immunoprecipitated with anti-FLAG antibody and Western blots were reacted with anti-FLAG
antibody.
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Fig. 4. Mutations introduced into the BR or LZ regions of K-bZIP affect
suppression of K-Rta-mediated transcriptional activation. (A) Vero cells were
cotransfected with either a wt K-bZIP expression plasmid or various BR- or LZ-
mutated K-bZIP expression plasmids, a K-Rta expression plasmid, and a
luciferase reporter plasmid that has the K-bZIP promoter driving the expression
of the luciferase gene. Data are shown as relative fold activation over luciferase
activity measured in cells transfected with only the K-bZIP luciferase reporter
plasmid. Total DNA for all transfection was equal and maintained by using
pGEM as filler DNA, except where noted. (B) K-bZIP BR-171/177/181
activates the PAN promoter. BR-171/177/181 was cotransfected with a PAN
promoter luciferase reporter plasmid along with a K-Rta expression plasmid.
Increasing amounts (2 μg, 5 μg, and 10 μg) of the BR-171/177/181 plasmid
were added to the transfection mixture.
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expression plasmids was used in the cotransfection co-
immunoprecipitation assay with a K-Rta expression plasmid.
All BR mutated K-bZIP proteins species were able to interact
with K-Rta (Fig. 3D). We also performed K-bZIP–K-Rta co-
immunoprecipitations using the K-bZIP leucine zipper mutants,
two of which, LZ-1 and LZ-2, failed to interact with wt K-bZIP.
Again all LZ mutants were capable of interacting with K-Rta
(Fig. 3E).
Since all of the K-bZIP proteins with amino acid residue
changes in either the BR or LZ domains were capable of
interacting with K-Rta, we next decided to evaluate the ability
of LZ or BR K-bZIP deletion mutants to interact with K-Rta in
the co-immunoprecipitation assay. We generated expression
plasmids where either the entire BR or LZ regions were deleted
(Fig. 3A). These plasmids were co-transfected with a K-Rta
expression plasmid and immunoprecipitations were preformed.
Surprisingly, both of these K-bZIP mutant proteins could
interact with K-Rta (Fig. 3F, lanes ΔBR and ΔLZ). The control
plasmid, where the entire BR/LZ region was removed from the
K-bZIP protein, failed to interact with K-Rta. This result
indicated that either the LZ or the BR domains could interact
with K-Rta. In order to confirm this finding, we used plasmid
clones that had either the LZ or BR domain deleted and then
introduced several point mutations into the remaining LZ or BR
region. These expression plasmids were cotransfected along
with a wt K-Rta expression plasmid and co-immunoprecipita-
tions were performed. An expression plasmid encoding a K-
bZIP protein species that lacked the entire BR and had leucine
residues 198 and 205 mutated interacted weakly with K-Rta
(Fig. 3G). A weak interaction was also observed when using a
plasmid clone that expressed a K-bZIP species that lacked the
entire LZ region and included mutations in amino acid residues
170/171/181/185 (Fig. 3G). No interaction was detected in
cotransfected cells using K-bZIP expression plasmids that
lacked the entire LZ domain and contained mutations in
residues 171/174/181/185 or 174/177/181/185 (Fig. 3G). These
experiments showed that both the BR and LZ of K-bZIP can
interact with K-Rta and that several amino acid residues within
the BR domain contribute to binding. Residues within the LZ
region that confer homodimerization also contribute to
heterodimerization.
The basic region, as well as leucine zipper region, contributes
to suppression of K-Rta-mediated transactivation
K-bZIP suppresses the transactivation function mediated by
K-Rta. This suppression appears to be promoter specific in that
two early promoters, those regulating the expression of K-bZIP
and ORF57, are down-regulated in the presence of K-bZIP (and
K-Rta), whereas the promoter responsible for the expression of
PAN is unaffected by K-bZIP. We wanted to evaluate the ability
of some of our LZ or BR mutants to suppress K-Rta-mediated
transactivation. Vero cells were transfected with a K-bZIP
promoter luciferase reporter plasmid (gift from H-S Kung, UC
Davis) along with plasmids expressing either wt K-bZIP or LZ
or BR mutants, and a K-Rta expression plasmid. Cells wereharvested 24 h post transfection and assayed for luciferase
activity. All luciferase activity comparisons were made against
basal K-bZIP promoter activity. As expected, wt K-bZIP
efficiently suppressed K-Rta-mediated transactivation of the
K-bZIP promoter (Fig. 4A, wt-K-bZIP). In addition, complete
removal of the LZ and BR domains resulted in a loss of
repressive function by K-bZIP (Fig. 4A). Some of the K-bZIP
BR mutants failed to suppress K-Rta-mediated activation of the
K-bZIP promoter (Fig. 4A, BR-171/181/185 and BR-170/171/
181/185). The K-bZIP recombinant with mutations in amino
acid residues 170/181/185 retained its ability to suppress K-Rta-
mediated transactivation similar to wt K-bZIP (Fig. 4A).
However, when the LZ domain was removed, this species lost
its ability to repress (Fig. 4A, BR-170/181/185 ΔLZ). These
data demonstrated that even in the presence of a protein–protein
interaction between K-bZIP and K-Rta, suppression of
transcriptional activation was dependent upon the retention of
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K-bZIP protein.
Interestingly, one BR mutant, BR-171/177/181, increased
the transactivation activity of K-Rta on the K-bZIP promoter
(Fig. 4A). This increased activity was over 5-fold higher than
that observed for K-Rta alone and over 100-fold higher than the
suppression mediated by wt K-bZIP (Fig. 4A). This positive
affect on K-Rta transactivation was also observed when using a
promoter (PAN) not normally regulated by K-bZIP (Izumiya et
al., 2003a). Nevertheless, when the K-bZIP mutant BR-171/
177/181 was cotransfected along with a K-Rta expression
plasmid and a PAN luciferase reporter plasmid, the activity of
the PAN promoter was shown to increase over 500-fold when
compared to PAN promoter alone and over 10-fold higher than
when K-Rta was present, with or without a wt K-bZIP
expression plasmid (Fig. 4B). As expected, the addition of a
wt K-bZIP expression plasmid had no effect on luciferase
activity from the PAN promoter (Fig. 4B).
Leucine zipper mutant LZ-2 also failed to suppress activation
of the K-bZIP promoter (Fig. 4A). This species contained
mutations in leucine residues 198 and 205. This result could
suggest that this region of the protein is important for binding
with K-Rta or may indicate that a K-bZIP–K-bZIP interaction is
a prerequisite for suppression of K-Rta-mediated activation.
This set of experiments showed that the BR of K-bZIP could
serve to regulate the activity of K-Rta in a negative, or in one
case, a positive manner.
The leucine zipper domain contributes to K-bZIP replication
function
Since it was previously demonstrated that K-bZIP supplied
an essential function in DNA replication, we next wanted to
identify important domains within the protein that contributed
to its function. It is known that mutations introduced into two of
the leucine residues within the putative leucine zipper abolished
the DNA replication function of K-bZIP (AuCoin et al., 2004b),
hence we sought to investigate the physical parameters behind
this observation. We next wanted to evaluate the ability of K-
bZIP mutants to complement oriLyt-dependent DNA replica-
tion. We previously demonstrated that the core replication
proteins plus K-Rta and K-bZIP were required for efficient
amplification of HHV8 oriLyt in the transient replication assay
(AuCoin et al., 2004a). We cotransfected core replication
proteins plus K-Rta, oriLyt, and the various K-bZIP mutants and
examined the ability of several mutants to complement oriLyt
amplification. Since it was demonstrated that K-bZIP was one
of the non-core proteins required for oriLyt-dependent DNA
replication, we wanted to investigate the role of the specific
protein domains of K-bZIP with respect to oriLyt-dependent
DNA replication. As mentioned earlier, it was previously
reported that K-bZIP is capable of forming both a homodimer
and heterodimer with K-Rta (Al Mehairi et al., 2005; Izumiya et
al., 2003a; Liao et al., 2003). It was shown here and previously
that the LZ domain of K-bZIP is required for interaction with K-
Rta and a mutant lacking the LZ domain no longer repressed K-
Rta-mediated transactivation (Liao et al., 2003). Further, it wasalso demonstrated that multimerization of K-bZIP is also
conferred through the LZ domain (Al Mehairi et al., 2005). In
addition, we have demonstrated that 2 key leucine residues
contribute to homodimerization and mutations of leucine
residues within the LZ region of K-bZIP inactivated the DNA
replication activity of the protein in the transient cotransfection
replication assay (AuCoin et al., 2004a). Our goals now were to
narrow down which leucine residues directly contributed to
DNA replication and determine if multimerization of K-bZIP is
necessary to confer the DNA replication activity of the protein.
Plasmids encoding mutated K-bZIP proteins were used in the
cotransfection–replication assay in place of wt K-bZIP. All of
the other required core replication proteins as well as K-Rta
were included in the mixture along with HHV-8 oriLyt. As a
control for demonstrating authentic amplification of oriLyt, we
treated all samples with either DpnI (and EcoRI), which cleaves
unmethylated/replicated DNA, or MboI, which has the same
base sequence recognition as DpnI but cleaves both methylated
and unmethylated DNA. Therefore any amplified oriLyt
plasmid will be cleaved when treated with MboI ensuring that
amplification of oriLyt occurred. Also, we ran duplicate gels of
cotransfected DNA that was cleaved with EcoRI alone and
performed Southern blots on these samples to show that an
equal amount of input oriLyt was in the transfection mixture and
in gel samples (Fig. 5B). K-bZIP species that lacked the entire
LZ or the BR region failed to complement oriLyt-dependent
DNA replication (Fig. 5A, lanes 3, 3* and 4, 4*). Also, the K-
bZIP LZ-1 and LZ-2 mutants failed to complement oriLyt
amplification indicating that these leucine residues are required
for the replication function and suggests that homodimerization
is essential (Fig. 5A, lanes 5, 5* and 6, 6*).
Repression of K-Rta-mediated transcriptional activation by
K-bZIP is not necessary for complementation of
oriLyt-mediated DNA replication
We also used the replication assay to evaluate K-bZIP
protein species with mutations in the BR domain. The K-bZIP
protein species lacking the entire BR failed to complement
oriLyt amplification in the transient cotransfection replication
assay (Fig. 5A, lanes 3 and 3*). However, those K-bZIP
mutants with mutations in the BR domain were still capable of
complementing oriLyt amplification, even those mutants that
failed to repress K-Rta-mediated transactivation (Fig. 5A, lanes
8–11 and 8*–11*). This result strongly suggests that the
repressive function of K-bZIP does not participate in DNA
synthesis. Interestingly, the K-bZIP mutant that conferred an
increase in K-Rta transcriptional activation also showed an
increase in oriLyt amplification indicating that increased
activity of K-Rta can lead to a higher accumulation of replicated
oriLyt. Both replication controls (MboI cleavage) and input
control show that the replicated product is authentic and similar
amounts of input oriLyt DNA were transfected.
Previously we demonstrated that the leucine zipper region of
K-bZIP was essential for conferring a replication function to the
protein (AuCoin et al., 2004a). We have now extended those
previous findings by showing that mutations introduced into
Fig. 5. Amino acid changes within the BR and the LZ motif affect the ability of K-bZIP to complement oriLyt-dependent DNA replication. Southern blot of DNA from
cotransfection–replication assay using Vero cells transfected with various K-bZIP mutants. All cotransfections included the core replication proteins, a K-Rta
expression plasmid, cloned oriLyt and wt K-bZIP, or various mutant K-bZIP expression plasmids as indicated. (A) Cells were cotransfected with K-bZIP expression
plasmids that produced mutated protein with amino acid changes in the BR. (∗lanes were treated withMboI) Lanes: 1, wt K-bZIP; 2, K-bZIP D6; 3, K-bZIP ΔBR; 4,
K-bZIP ΔLZ; 5, K-bZIP LZ-1; 6, K-bZIP LZ-2; 7, wt K-bZIP; 8, BR-171/177/181; 9, BR-170/171/181/185; 10, BR-170/181/185; 11, BR-171/181/185; 12, No K-
bZIP. (B) OriLyt input control. Southern of total cell DNA extracted from cotransfected Vero cells cleaved with EcoRI only and hybridized with a probe specific for
HHV8 oriLyt sequences.
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the activity of K-bZIP in the origin-dependent replication assay.
The results presented here show that leucine residue 205, along
with residue 198 from the previous studies, are key amino acids
with respect to DNA replication and homodimerization. One
ramification of mutations within the leucine zipper region is that
these mutations no longer allow for a K-bZIP–K-bZIP
interaction. This suggests that dimerization of K-bZIP is
essential for complementation of DNA replication.
Dimerization appears not to be necessary for the interac-
tion of K-bZIP with K-Rta. K-bZIP mutant LZ-2 still
interacted with K-Rta although it no longer complemented
oriLyt-dependent DNA replication. This result can be
interpreted two ways: (i) it could be that K-bZIP interacts
with K-Rta as a monomer or (ii) it is essential that K-bZIP be
in a dimer or multimer state when binding to K-Rta and it is
this structure that contributes to activity. In a previous report,
the BR of K-bZIP was implicated as the domain that interacts
with K-Rta (Izumiya et al., 2003a). It also appears that the
regulatory function of K-bZIP is distinct from the replication
function. This is exemplified by the fact that a K-bZIP BR
mutant was still capable of complementing oriLyt-dependent
DNA replication but was not able to suppress K-Rta-mediated
transactivation.
Our results show that both the LZ and BR domains can
interact with K-Rta. This may explain the apparent conflicting
results from studies seeking to identify the K-bZIP domain that
interacts with K-Rta (Izumiya et al., 2003a; Liao et al., 2003). It
is clear from the results shown in this report that both structures
contribute to the interaction of K-bZIP with itself, to the
suppression of K-Rta, and to DNA replication.Mutations introduced into the BR did not affect K-bZIP
homodimerization but this domain still may be required for an
as yet unidentified DNA–protein interaction. Indeed the
complete removal of either the BR or LZ regions resulted in a
loss of replication function. Interestingly, even though efficient
binding was observed in co-immunoprecipitation experiments,
mutations in the BR locus still affected the ability of K-bZIP to
suppress the transactivation activity of K-Rta. This strongly
suggests that inhibition of transactivation is not exclusively due
to a protein–protein interaction. While others have investigated
the role of specific elements in the repression of transcriptional
activation by K-Rta, ours is the first study to evaluate the effects
of specific amino acid residue changes within K-bZIP,
particularly in the BR. Recently, it was shown that SUMO
modification was partly responsible for transcriptional repres-
sion activity of K-bZIP (Izumiya et al., 2005). Sumoylation was
shown to occur at lysine residue 158, a residue that was not
altered in our studies. In addition, phosphorylation also plays a
role in the repressive activity of K-bZIP on K-Rta-mediated
transactivation (Izumiya et al., 2007). These data and the results
presented here suggest that regulation of repression activity of
K-bZIP is controlled by multiple elements and mechanisms. It is
worth noting that another splice variant of K-bZIP exists in cells
harboring viral DNA. This splice variant, K8β, contains the
upstream basic region but not the C-terminal leucine zipper
domain (Yamanegi et al., 2005). The K8β variant apparently
serves to antagonize the activity of K-bZIP. The studies
presented here involving the leucine zipper domain of K-bZIP
would not affect the antagonistic function of K8β.
One BR mutant, BR-171/177/181, surprisingly increased the
activity of K-Rta with respect to transcriptional activation of
347C. Rossetto et al. / Virology 369 (2007) 340–350both the K-bZIP and PAN promoters. This result may be due to
a change in the mode in which K-bZIP interacts with K-Rta,
which may subsequently alter the binding of K-Rta, directly or
indirectly, to K-Rta-binding sites within these promoters,
leading to increased activity. This effect was also confirmed in
the cotransfection replication assay where the addition of this
BR mutant in the cotransfection mixture led to an increased
intensity of amplified oriLyt. HHV8 oriLyt contains an ORF50
Response Element (RE) that is an almost exact copy of the
PAN promoter ORF50RE. The apparent reason for an
increased amplification signal for oriLyt is probably due to
an up-regulation of transcriptional activation, from K-Rta,
within oriLyt similar to what was observed with the K-bZIP
promoter. Recently, it was postulated that the ORF50REs in K-
Rta-responsive promoters fall into two groups (Chang et al.,
2005). The interaction of K-Rta with the K-bZIP and ORF57
promoter may be indirect, in that cellular transcription factors
may be involved and may indicate an increased affinity for
RBP-Jκ or increase the binding of the K-Rta complex for
DNA.
A recent study suggested that K-bZIP may serve to recruit
the core DNA replication enzymes and K-Rta to oriLyt (Wang
et al., 2006). This recruitment could be in conjunction with
transcription factors such as C/EBPα and the viral transacti-
vator K-Rta. It is clear from the data presented here that the
leucine zipper and basic regions contribute to the activity of K-
bZIP and K-bZIP may aid in the function of K-Rta within
oriLyt. Another scenario is that, in the context of the viral
genome, K-bZIP may serve a dual role: (i) as a negative
regulator of DNA replication by controlling the effects of K-
Rta, and (ii) supplying an as yet undefined enzymatic function
to lytic DNA replication, independent of its observed suppres-
sion activity.
Materials and methods
Plasmids
The set of plasmids expressing the HHV8 core replication
genes, K-Rta and K-bZIP, was previously described (AuCoin et
al., 2004a).
K-bZIP site-directed mutagenesis
A parent K-bZIP expression plasmid was generated by
subcloning the K-bZIP ORF into pCMV Xi (Genlantis) such
that either an in frame HA or FLAG tag was added. Site-
directed point mutations were introduced into the K-bZIP ORF
using QuickChange mutagenesis kit (Stratagene) according to
manufacture's instructions. For the introduction of several
different base pair changes, we subjected plasmids to multiple
rounds of mutagenesis. Primers were used such that amino acids
were changed to alanine residues in the basic regions and to
valine residues in the leucine zipper region. The individual
plasmid names within the figures indicate which amino acid
changes were made; all plasmids were sequenced and the entire
ORF was examined to ensure that the proper mutation wasmade. For leucine zipper mutants: LZ-1, primer 5′-GATGCA-
CAAGTATGTTTCGTAGCGGCGAGATTGGAGGCACA-
TAAG-3 was used and the resulting mutant was used with primer
5′-AGGAACAGATTATTTTCCGTCGCGACATGCTGATGC-
GAATGTGCCAGC-3′; for LZ-2, primer 5′-GAAAAGGATG-
CACAAGTATGTTTCCTAGCGGCGAGAGTGGAGGCACA-
TAAGGAACAG-3′ was used; for LZ-3, primer 5′-AAGGATG-
CACAAGTATGTTTCGTAGCGGCGAGATTGGAGGCACA-
TAAG-3′ was used. Primers used to generate BR mutants and
other mutants are listed in Table 1.
Cotransfection replication assay
Vero cells were transfected with the complete set of core
replication proteins and wild-type or mutated K-bZIP expres-
sion plasmids. A K-Rta expression plasmid was included in the
transfection mixture when using wild-type oriLyt but was
omitted when using oriLyt plasmids containing the HCMV
MIEP. Assays were performed as previously described (AuCoin
et al., 2004a). To test K-bZIP BR or LZ mutants, the compete
set of replication plasmids, along with a K-Rta expression
plasmid and pDA15, were included in the transfection mixture.
Mutant K-bZIP-encoding plasmids were substituted for a wt K-
bZIP expression plasmid.
Antibodies
Mouse monoclonal anti-FLAG antibody (Sigma, St. Louis,
MO) and mouse monoclonal anti-HA antibody (Sigma) were
used as primary antibodies for immunoprecipitation and
immunoblotting analysis; horseradish peroxidase-conjugated
goat anti-mouse IgG (Santa Cruz Biotechnology, Santa Cruz,
CA) were used as secondary antibodies. M2 monoclonal mouse
anti-FLAG-conjugated agarose beads (Sigma, St. Louis, MO)
were used for the immunoprecipitation of FLAG-tagged K-
bZIP proteins and complexes. A K-Rta antibody (gift from D.
Ganem, UC San Francisco) was also used in co-immunopre-
cipitations. The anti-K-bZIP antibody was generated at the
University of Nevada Monoclonal Antibody Facility using
antigen purified from mammalian (Vero) cells.
Co-immunoprecipitation and Western analysis
Ten-centimeter dishes of 293FT cells were transfected with
5 μg of wild-type HA-tagged K-bZIP expression plasmid and
5 μg of FLAG-tagged K-bZIP mutant expression plasmid using
the TransIt LT1 Transfection Reagent (Mirus, Madison, WI).
Protein was harvested from the transfected 293FT cells 24–48 h
after transfection. The transfected 293FT cells were rinsed twice
with ice-cold PBS (phosphate-buffered saline solution, 10 mM
NaPO4, 137 mM NaCl, 2.5 mM KCl, pH 7.5) and lysed in lysis
buffer (50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% Triton X,
0.1% Tween 20, pH 7.5) with 10 μl/ml protease inhibitor
cocktail for mammalian tissues (Sigma, St. Louis, MO). DNA
was sheared by passing the lysate three times through a 22-gauge
needle, and cell debris was cleared by centrifugation at 12,000×g
for 10 min at 4 °C. The K-bZIP–K-bZIP immunocomplex was
Table 1
Primers used to generate site-directed K-bZIP mutants
Mutant Oligonucleotide sequence
BR-A171/174/185 F BR-A171/174 Template+Primer for BR-A185
RC BR-A171/174 Template+Primer for BR-A185
BR-A170/177/181 F BR-A177/181 Template+Primer for BR-A170
RC BR-A177/181 Template+Primer for BR-A170
BR-A171/177/181 F BR-A177/181 Template+Primer for BR-A171
RC BR-A177/181 Template+Primer for BR-A171
BR-A170/171/177/181 F BR-A177/181 Template+Primer for BR-A170/171
RC BR-A177/181 Template+Primer for BR-A170/171
BR-A171/174/185 F BR-A181/185 Template+Primer for BR-A170
RC BR-A181/185 Template+Primer for BR-A170
BR-A171/181/185 F BR-A181/185 Template+Primer for BR-A171
RC BR-A181/185 Template+Primer for BR-A171
BR-A174/181/185 F BR-A181/185 Template+Primer for BR-A174
RC BR-A181/185 Template+Primer for BR-A174
BR-A170/171/181/185 F BR-A181/185 Template+Primer for BR-A170/171
RC BR-A181/185 Template+Primer for BR-A170/171
BR-A171/174/181/185 F BR-A181/185 Template+Primer for BR-A171/174
RC BR-A181/185 Template+Primer for BR-A171/174
BR-A174/177/181/185 (BR-A174/177 Template) F 5′-GGCGCCGTGTCATCGGCAGCATACACAGCACAGCTGCAGCAG- 3′
RC 5′- GCCTGCTGCAGCTGTGCTGTGTATGCTGCCGATGACACGGCGC- 3′
Deletion 1 F 5′-AGCTCAAGCTTCGAATTCATGTTTTTTACGGACAATACTG-3′
RC 5′-CAGTATTGTCCGTAAAAAACATGAATTCGAAGCTTGAGCT-3′
Deletion 2 F 5′-AGCCTCAACGGGCAACCAGAAACGGTCATTGACCTTACAG-3′
RC 5′-CTGTAAGGTCAATGACCGTTTCTGGTTGCCCGTTGAGGCT-3′
Deletion 3 F 5′-CCCGGCCATACCGGTCTGTCCTTCCTGGACGCTCTCTC-3′
RC 5′-GAGAGAGCGTCCAGGAAGGACAGACCGGTATGGCCGGG-3′
Deletion 4 F 5′-TAAATTCCACATCCCCGATGAACGCTTATGCACTAAGG-3′
RC 5′-CCTTAGTGCATAAGCGTTCATCGGGGATGTGGAATTTA-3′
Deletion 5 F 5′-ACATAGAAAGTTTGAAGAGCAAGGCAGATACGGCCGCG-3′
RC 5′-CGCGGCCGTATCTGCCTTGCTCTTCAAACTTTCTATGT-3′
Deletion 6 F 5′-GTCACATTCTCCCACGCGAAAGGAGGCACATAAGGAACAGA-3′
RC 5′-TCTGTTCCTTATGTGCCTCCTTTCGCGTGGGAGAATGTGAC-3′
Deletion 7 F 5′-CCTAGCGGCGAGATTGGATTACAAGGATGACGACGATAAGTG-3′
RC 5′-CACTTATCGTCGTCATCCTTGTAATCCAATCTCGCCGCTAGGA-3′
NO BR F 5′-GTATGTGATCAGTCACATTCTCCCCAGCTGCAGCAGGCATTA-3′
RC 5′-TAATGCCTGCTGCAGCTGGGGAGAATGTGACTGATCACATAC- 3′
NO LZ F 5′-AAGACAGCTGCAGCAGGCAATGCGAATGTGCCAGCAGCCAG-3′
RC 5′-CTGGCTGCTGGCACATTCGCATTGCCTGCTGCAGCTGTCTTGT-3′
LZ-1 (LZ-3 Template) F 5′-CATAAGGAACAGATTATTTTCGTTCGCGACATGCTGATGCGA-3′
RC 5′-TCGCATCAGCATGTCGCGAACGAAAATAATCTGTTCCTTATG-3′
LZ-2 F 5′-GATGCACAAGTATGTTTCCTAGCGGCGAGAGTGGAGGCACAT-3′
RC 5′-ATGTGCCTCCACTCTCGCCGCTAGGAAACATACTTGTGCATC-3′
LZ-3 F 5′-GAAAAGGATGCACAAGTATGTTTCGTAGCGGCGAGATTGGAG-3′
RC 5′-CTCCAATCTCGCCGCTACGAAACATACTTGTGCATCCTTTTC-3′
NO BR – V198/205 F LZ-2 Template+Primer for NO BR
RC LZ-2 Template+Primer for NO BR
NO LZ – A170/171/181/185 F BR-A170/171/181/185 Template+Primer for NO LZ
RC BR-A170/171/181/185 Template+Primer for NO LZ
NO LZ – A171/174/181/185 F BR-A171/174/181/185 Template+Primer for NO LZ
RC BR-A171/174/181/185 Template+Primer for NO LZ
NO LZ – A174/177/181/185 F BR-A174/177/181/185 Template+Primer for NO LZ
RC BR-A174/177/181/185 Template+Primer for NO LZ
F=forward primer; RC=reverse complement primer.
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monoclonal antibody-conjugated agarose beads (Sigma, St.
Louis, MO) and incubation overnight at 4 °C with gentle
rotation. The beads were washed three times for 5 min each in
TBS (50 mM Tris–HCl, 150 mM NaCl, pH 7.4) and then boiled
for 5 min in 70 μl of Laemli sample buffer-5% β-mercaptoetha-
nol (Bio-Rad, Hercules, CA) to denature the anti-FLAGantibodies and elute the K-bZIP–K-bZIP immunocomplex.
Protein samples from the cell lysate and the immunoprecipitated
protein were separated by 10%-SDS polyacrylamide gel
electrophoresis and then transferred onto 22 μm polyvinyldene
difluoride membrane (Bio-Rad, Hercules, CA) using a semidry
transfer apparatus (Bio-Rad, Hercules, CA). After blocking
non-specific antigen binding for 15 min at room temperature in
349C. Rossetto et al. / Virology 369 (2007) 340–350TBST (20 mM Tris–HCl, 137 mM NaCl, 0.05% Tween 20,
pH 7.6)-5% skim milk, the membranes were incubated with
primary antibodies for 1 h at room temperature or overnight at
4 °C with gentle rotation. Protein species within each
immunoprecipitate were detected using anti-HA antibody and
separately using anti-FLAG antibody, to detect the presence of
both wild-type (HA-tagged) and mutant (FLAG-tagged) K-
bZIP. The final dilution of the M2 mouse monoclonal anti-
FLAG primary antibody used was 1:5000. After incubation
with primary antibody, the membranes were washed with
TBST for 15 min at room temperature, with rotation. The
membranes were then incubated with horseradish peroxidase
(HRP)-conjugated goat anti-mouse IgG secondary antibody
(1:5000 dilution) for 30 min at room temperature, then washed
with TBST for 15 min at room temperature. The membranes
were exposed for 5 min using a chemiluminescent HRP
substrate (SuperSignal West Femto Maximum Sensitivity
Substrate, Pierce, Madison, WI), and visualized using a Bio-
Rad Chemi Doc.
Luciferase reporter assay
Vero cells were cotransfected with pGL3-K-bZIP promoter
(provided by H-S Kung, UC Davis), a K-Rta expression
plasmid (AuCoin et al., 2004a), and plasmids expressing K-
bZIP BR or LZ mutants. Cells were lysed and standard
luciferase detection was performed (Promega). Each assay was
measured in triplicate and each experiment was repeated three
times. A representative experiment is shown.
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